A61M2210/1053

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS
20230050453 · 2023-02-16 ·

Various embodiments disclosed relate to drug-coated balloon catheters for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent. In some embodiments, the balloon catheter includes a length-control mechanism which stretches and elongates the balloon when it is in a deflated state, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.

Retrieval systems and related methods

Drug delivery articles, resident articles, and retrieval systems e.g., for gram-level dosing, are generally provided. In some embodiments, the articles are configured for transesophageal administration, transesophageal retrieval, and/or gastric retention to/in a subject. In certain embodiments, the article includes dimensions configured for transesophageal administration with a gastric resident system. In some cases, the article may be configured to control drug release e.g., with zero-order drug kinetics with no potential for burst release for weeks to months. In some embodiments, the articles described herein comprise biocompatible materials and/or are safe for gastric retention. In certain embodiments, the article includes dimensions configured for transesophageal retrieval. In some cases, the articles described herein may comprise relatively large doses of drug (e.g., greater than or equal to 1 gram).

Face mask for non-invasive mechanical ventilation with low value of CO.SUB.2 .rebreathing
11565065 · 2023-01-31 · ·

A face mask (also called full face) for respiratory therapy, in particular for non-invasive mechanical ventilation, has a low value of CO.sub.2 rebreathing. The mask includes a shaped shell to cover at least the mouth, the nose and the eyes of a patient when the mask is worn, and includes, on said shaped shell an inlet fitting for the connection to a pipe through which a ventilation apparatus supplies the mask with a mixture of air and oxygen, and an outlet fitting, separate from said inlet fitting, for the discharge of air exhaled by the patient. With this arrangement, the mask allows drastically reducing the phenomenon of carbon dioxide rebreathing, which is very harmful for the patient subjected to ventilation.

Endoscopic dilator
11565092 · 2023-01-31 · ·

A dilator releasably connected with an endoscope to dilate a stricture as the dilator that is releasably connected to a portion of a cylindrical body of the endoscope passes through the stricture. The endoscopic dilator is moveable between an open position and a closed position configured to enable the dilator to be secured to the endoscope. When the dilator is in the closed position, an inner surface or a component on the inner surface of the dilator frictionally secures dilator to the portion of the cylindrical body of the endoscope. When in the open position, the dilator is not frictionally secured to the portion of the cylindrical body of the endoscope.

Devices, systems, and methods for delivering therapeutic agents into a stomach wall
11565095 · 2023-01-31 · ·

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents (TA) within the GI tract and in particular to an antrum wall (AW). Particular embodiments provide a swallowable device (SD) such as a capsule for delivering drugs or other TA into the AW. The SD may contain a pressure sensitive component or assembly which triggers release and insertion of a therapeutic agent preparation (TAP) comprising at least one TA into the AW in response to external pressure, such as pressure applied to the swallowable capsule or other SD by antrum contractions. Particular embodiments of the SD may be shaped so that they self-align within an antrum to properly orient before injection of the TAP into the AW. Embodiments of the invention are particularly useful for orally delivering drugs or other TAs which are degraded within the GI tract and require parenteral injection.

Tubing system with operation mode communication
11701029 · 2023-07-18 · ·

A capnography system includes a CO.sub.2 sensing system having a CO.sub.2 sensor configured to measure a CO.sub.2 concentration in exhaled breath of a subject, a processor configured to derive one or more breath related parameters based on the measured CO.sub.2 concentration, and a communication unit. The capnography system includes a tubing system configured to allow flow of respiratory gasses therethrough. The tubing system includes a connector configured to connect the tubing system to the CO.sub.2 sensing system and a communication component configured to provide an indication of a type of the tubing system to the communication unit. The communication unit is configured to transfer data to the processor based on the indication obtained from the communication component, and the processor is configured to change or suggest a change of an operation mode of the CO.sub.2 sensing system based on the data.

SELF-RIGHTING SYSTEMS, METHODS, AND RELATED COMPONENTS

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface. In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent. In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components. In some cases, the tissue interfacing component may comprise and/or be associated with the pharmaceutical agent.

Long acting gastric residence system

The present disclosure is in the field of gastroretentive dosage forms. A gastroretentive dosage form for extended retention in a stomach is provided.

GASTRIC RESIDENCE SYSTEMS HAVING A FILAMENT FOR IMPROVED GASTRIC RESIDENCE

Provided are gastric residence systems comprising: a core; a plurality of arms connected to the core at a proximal end through a plurality of linker components, one linker component of the plurality of linker components corresponding to each arm of the plurality of arms, and the plurality of arms extending radially from the proximal end, and a filament circumferentially connecting each arm of the plurality of arms.

Apparatus and method for continuous monitoring of gastric content volume
11523974 · 2022-12-13 ·

A method and apparatus for determining gastric content volume. The internal temperature of the contents of the stomach is measured at least one predetermined time t after the patient is fed, and the gastric volume determined from the temperature. In preferred embodiments, a known volume of water at a known temperature is injected into the stomach, and the temperature of the stomach contents is measured after the stomach temperature has stabilized. An apparatus for performing the method, in which continuous measurement is possible without disturbing the patient's feeding schedule, and a method for using the inventive method in the control of an automatic feeding apparatus, are also disclosed.